205 related articles for article (PubMed ID: 30770798)
1. MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway.
Zou H; Chen Q; Zhang A; Wang S; Wu H; Yuan Y; Wang S; Yu J; Luo M; Wen X; Cui W; Fu W; Yu R; Chen L; Zhang M; Lan H; Zhang X; Xie Q; Jin G; Xu C
Cell Death Dis; 2019 Feb; 10(3):148. PubMed ID: 30770798
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling.
Zhang Y; Ma P; Duan Z; Liu Y; Mi Y; Fan D
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216134
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression.
Wang ML; Hsu YF; Liu CH; Kuo YL; Chen YC; Yeh YC; Ho HL; Wu YC; Chou TY; Wu CW
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957649
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition.
You JH; Lee J; Roh JL
Cancer Lett; 2021 Jun; 507():40-54. PubMed ID: 33741422
[TBL] [Abstract][Full Text] [Related]
5. MPC1 Deficiency Promotes CRC Liver Metastasis via Facilitating Nuclear Translocation of
Tian GA; Xu CJ; Zhou KX; Zhang ZG; Gu JR; Zhang XL; Wang YH
J Immunol Res; 2020; 2020():8340329. PubMed ID: 32851100
[TBL] [Abstract][Full Text] [Related]
6. Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F.
Esteves P; Dard L; Brillac A; Hubert C; Sarlak S; Rousseau B; Dumon E; Izotte J; Bonneu M; Lacombe D; Dupuy JW; Amoedo N; Rossignol R
Oncogene; 2020 Jan; 39(3):617-636. PubMed ID: 31527668
[TBL] [Abstract][Full Text] [Related]
7. Two human patient mitochondrial pyruvate carrier mutations reveal distinct molecular mechanisms of dysfunction.
Oonthonpan L; Rauckhorst AJ; Gray LR; Boutron AC; Taylor EB
JCI Insight; 2019 May; 5(13):. PubMed ID: 31145700
[TBL] [Abstract][Full Text] [Related]
8. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression.
Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
[TBL] [Abstract][Full Text] [Related]
9. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma.
Yang Y; Zhu J; Zhang T; Liu J; Li Y; Zhu Y; Xu L; Wang R; Su F; Ou Y; Wu Q
J Exp Clin Cancer Res; 2018 Mar; 37(1):65. PubMed ID: 29566713
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial pyruvate carrier 1 functions as a tumor suppressor and predicts the prognosis of human renal cell carcinoma.
Tang XP; Chen Q; Li Y; Wang Y; Zou HB; Fu WJ; Niu Q; Pan QG; Jiang P; Xu XS; Zhang KQ; Liu H; Bian XW; Wu XF
Lab Invest; 2019 Feb; 99(2):191-199. PubMed ID: 30291323
[TBL] [Abstract][Full Text] [Related]
11. MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer.
Wang L; Xu M; Qin J; Lin SC; Lee HJ; Tsai SY; Tsai MJ
Oncotarget; 2016 Mar; 7(12):14673-83. PubMed ID: 26895100
[TBL] [Abstract][Full Text] [Related]
12. Reduced CENPU expression inhibits lung adenocarcinoma cell proliferation and migration through PI3K/AKT signaling.
Li J; Wang ZG; Pang LB; Zhang RH; Wang YY
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1077-1084. PubMed ID: 30849291
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of novel MPC1 gene variants causing mitochondrial pyruvate carrier deficiency.
Jiang H; Alahmad A; Fu S; Fu X; Liu Z; Han X; Li L; Song T; Xu M; Liu S; Wang J; Albash B; Alaqeel A; Catalina V; Prokisch H; Taylor RW; McFarland R; Fang F
J Inherit Metab Dis; 2022 Mar; 45(2):264-277. PubMed ID: 34873722
[TBL] [Abstract][Full Text] [Related]
14. MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma.
Chai Y; Wang C; Liu W; Fan Y; Zhang Y
J Neurooncol; 2019 Sep; 144(2):293-301. PubMed ID: 31236818
[TBL] [Abstract][Full Text] [Related]
15. miR-21-5p promotes lung adenocarcinoma progression partially through targeting SET/TAF-Iα.
Zhong J; Ren X; Chen Z; Zhang H; Zhou L; Yuan J; Li P; Chen X; Liu W; Wu D; Yang X; Liu J
Life Sci; 2019 Aug; 231():116539. PubMed ID: 31176779
[TBL] [Abstract][Full Text] [Related]
16. Generation of an induced pluripotent stem cell line (BCHNCi003-A) from a patient with mitochondrial pyruvate carrier deficiency caused by biallelic MPC1 mutations.
Jiang H; Xu C; Li W; Zhou L; Fang F
Stem Cell Res; 2023 Oct; 72():103206. PubMed ID: 37769383
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LEISA promotes progression of lung adenocarcinoma via enhancing interaction between STAT3 and IL-6 promoter.
Wu S; Liu B; Zhang Y; Hong R; Liu S; Xiang T; Tao T; Cai J; Wu J; Li M; Guan H
Oncogene; 2021 May; 40(19):3449-3459. PubMed ID: 33859372
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
[TBL] [Abstract][Full Text] [Related]
19. GRAIL inhibits the growth, migration and invasion of lung adenocarcinoma cells by modulating STAT3/C-MYC signaling pathways.
Zhu Y; Feng YZWWJ
J BUON; 2021; 26(2):353-358. PubMed ID: 34076979
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.
Ohashi T; Eguchi H; Kawamoto K; Konno M; Asai A; Colvin H; Ueda Y; Takaoka H; Iwagami Y; Yamada D; Asaoka T; Noda T; Wada H; Gotoh K; Kobayashi S; Koseki J; Satoh T; Ogawa K; Doki Y; Mori M; Ishii H
Oncol Rep; 2018 Mar; 39(3):1276-1282. PubMed ID: 29286150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
